Navigation Links
New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation
Date:7/30/2008

- Results Presented at ICAD 2008 Highlight Significant Improvement in

Cognitive Performance and Global Clinical Status in Patients with

Alzheimer's Disease -

CHICAGO, July 30 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) presented today positive Phase III data of a once-daily extended-release formulation of Namenda(R) (memantine HCl) at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD). The study evaluated the efficacy, safety and tolerability of an innovative, proprietary, 28 mg once-daily extended-release formulation of Namenda compared to placebo in outpatients with moderate to severe Alzheimer's disease already being treated with a cholinesterase inhibitor (donepezil, galantamine or rivastigmine).

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

In the study, patients treated with once-daily extended-release Namenda experienced significant improvements in cognitive performance and global clinical status compared to those receiving placebo. Patients treated with once-daily extended-release Namenda also experienced significant improvements in verbal fluency and behavioral symptoms as compared to placebo. The results build on preliminary findings announced by Forest in February.

"While there is no cure or existing treatment to prevent Alzheimer's disease, there are currently-available FDA-approved treatments, such as combination therapy with memantine and a cholinesterase inhibitor, which can alleviate symptoms by providing cognitive, functional, and behavioral benefits," said George Grossberg, MD, Director of Geriatric Psy
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Focal Cryoablation Highlighted in Urology Times Best of AUA Orlando 2008
2. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
3. Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
4. Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
5. June 2008 Mayo Clinic Womens HealthSource Highlights Shingles Vaccine for Pain Prevention, Tips to Avoid Antibiotic Resistant Infections, and Benefits of Broad Genetic Testing
6. New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI
7. Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
8. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
9. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
10. ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
11. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... CHICAGO, Ill. , Sept. 22, 2014 /PRNewswire/ ... data from several clinical studies evaluating potential new ... presented at the upcoming 2014 European Society of ... Madrid, Spain . Data being ... evaluating the safety and efficacy of veliparib (ABT-888), ...
(Date:9/22/2014)... DIEGO , Sept. 22, 2014 Arena Pharmaceuticals, ... company is scheduled to present a corporate overview and ... on Friday, September 26, 2014, at 11:30 a.m. Eastern ... Hotel in New York City . ... will be available under the investor relations section of ...
(Date:9/22/2014)... , September 22, 2014 ... Line Development Market by Product (Equipment, Media and Reagents), ... Engineering & Regenerative medicine, Toxicity Testing, Research, Drug ... published by MarketsandMarkets, analyzes and studies the major ... Browse 114 market data tables and 64 ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4
... PARSIPPANY, N.J., Jan. 31, 2011 PDI, Inc. (Nasdaq: ... officer, is scheduled to present at the UBS 21st Annual Global ... at the Grand Hyatt New York. The live ... company,s website at http://www.pdi-inc.com . The webcast will be archived ...
... Calif., Jan. 31, 2011 OXIS International, Inc., (OTC ... today announced highly favorable final results from an initial ... patent-pending ERGOFLEX™ joint health formula, launched commercially ... of pain was statistically significant after as little as ...
Cached Medicine Technology:Final Results from ERGOFLEX Study Show Statistically Significant Reduction in Joint Pain in as Little as One Week 2Final Results from ERGOFLEX Study Show Statistically Significant Reduction in Joint Pain in as Little as One Week 3Final Results from ERGOFLEX Study Show Statistically Significant Reduction in Joint Pain in as Little as One Week 4
(Date:9/22/2014)... WI (PRWEB) September 22, 2014 ... in the United States, promotes National Self-Improvement ... believes that all individuals should have access to ... in aging. , The demand for products that ... longer than ever before. For over six years, ...
(Date:9/22/2014)... Va. (PRWEB) September 22, 2014 ... the nation’s leading nonprofit authority on the ... healthcare information exchange, announced findings from its recent ... Health Plan Identifier (HPID) within electronic transactions adopted ... (HIPAA). WEDI conducted the survey from August 20 ...
(Date:9/22/2014)... MONDAY, Sept. 22, 2014 (HealthDay News) -- Two new ... Administration (FDA) may provide some relief for people with ... to a new study. One device -- the ... other device -- the Cerena -- is meant to ... FDA news release. "Patients have been looking for ...
(Date:9/22/2014)... 22, 2014 Pain does not need to ... a user- and reader-friendly book designed to guide the individual ... living. This inspirational book is written to help the reader ... a way to regain a pain-free life — a daily ... pain. , Chronic pain has become an epidemic, with over ...
(Date:9/22/2014)... 22, 2014 PCI (Project Concern ... to equip women around the world with tools and ... the Women Empowered (WE) Initiative announced at the CGI ... groups to pool their savings, invest in their own ... solution to ending poverty in the world, and through ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 2Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 3
... a young Indian American is hard put to find a ... South Asians are listed in the US Bone Marrow registry. ... a disease known as Acute Myelogenous Leukemia (or AML), a ... Asian community has come together nationwide to help him and ...
... International Diabetes Federation (IDF) today called for projects that ... with diabetes and to implement practical solutions for improving ... as BRIDGES (Bringing Research in Diabetes to Global Environments ... Congress in Cape Town, South Africa and was officially ...
... ice sheet to break up, even though the air over ... at least a century, according to a new study ... ,As part of their study, the team led by ... how high the ice had deposited boulders in Antarctica's Framnes ...
... Echinacea, a medicinal herb that came to prominence thanks to its ... catching a cold, a wide-scale study has confirmed. ,Taking ... percent and may also shorten the duration of a cold almost ... Sunday in the July issue of the journal The Lancet Infectious ...
... studies have found that new adjuvant treatments for breast ... Published in the August 1, 2007 issue of Cancer, ... studies looked at the cost-effectiveness of different drugs for ... ,In a Canadian economic study of estrogen ...
... Six World Heritage sites, including Mount Everest, could be at ... experts and groups . ,Urging the United Nations ... the Climate Justice Programme have petitioned the global body to ... that have signed the UN World Heritage Convention have a ...
Cached Medicine News:Health News:South Asians Seek Bone Marrow for Young Indian American 2Health News:The International Diabetes Federation Launches US$ 10 Million Grant to Improve Diabetes Care 2Health News:The International Diabetes Federation Launches US$ 10 Million Grant to Improve Diabetes Care 3Health News:Sioux Herb Confirmed as Shield Against Colds 2Health News:New Adjuvant Breast Cancer Treatments Found Cost-effective 2Health News:Everest, Five Other World Heritage Sites Face Climate Change Risk 2
Indications For Usage: ,Airway management during anesthesia or short-term surgical procedures....
Indications For Usage: , When patient's head is in an extended or flexed position When patient will be turned over. , Long-term cases where maintenance of an airway is critical. , Neurosurgical pr...
Indications For Usage: ,Airway management during pediatric surgical procedures and intensive care....
... Detector/Clamp adds air detection and automatic clamping capability ... Fluid Warmer., ,The potential of air embolism ... known. Currently, health care professionals rely primarily on ... has lead to the safe use of the ...
Medicine Products: